FIG 3.
Distribution of VL among 284 patients receiving ART and 70 untreated individuals in Malawi and Uganda. VL was determined with Roche TaqMan v2.
Distribution of VL among 284 patients receiving ART and 70 untreated individuals in Malawi and Uganda. VL was determined with Roche TaqMan v2.